Drug reference
pritelivir
Investigational Antiviral agent (helicase–primase inhibitor)
Investigational Antiviral agent (helicase–primase inhibitor)
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Pritelivir inhibits the helicase–primase complex required for replication of HSV.
Related guidelines
Other Unclassified drugs
Ask House about pritelivir
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team